Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system...
Neuroscience
Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
Single Infusion of ANX005 Demonstrated Significant Improvements Across Multiple Functional and Prognostic Measures That Expedited Recovery in GBS Patients ANX005...
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and...
Pancreatic cancer’s cellular amnesia
COLD SPRING HARBOR, N.Y., June 17, 2024 /PRNewswire/ -- Things aren't always as they seem. Take pancreatic cancer, for example. In...
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024MALVERN, Pa., June...
MYndspan announces new study that accurately predicts brain age across the lifespan
Published in Imaging Neuroscience, "Predicting brain age across the adult lifespan" was able to identify and model the arcs of...
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
Company to host webcast on Tuesday, June 18, 2024, at 8:00 AM Eastern Time Oral presentation by Elsa Rossignol, M.D., FRCP,...
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment...
Tampa General Hospital Deploys Artificial Intelligence Tools to Elevate Patient Experience
Ambient listening eliminates hours of documentation so providers can focus on patients and their care. TAMPA, Fla., June 11, 2024...
Mount Sinai Medical Center Selects HealthSnap Remote Patient Monitoring and Chronic Care Management Platform to Support Chronic Disease Management Programs
The partnership launches full-service RPM and CCM for chronic condition management with plans to expand across 13 Mount Sinai locations...
Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials
Cumulus to participate in The Digital Health Measurement Collaborative Community (DATAcc) by DiMe project – Building the Business Case for...
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
With Growing Body of Clinical Evidence, ALX-001 is Ready to Commence Phase 2 StudiesNEW HAVEN, Conn., June 11, 2024 (GLOBE...
Cutera® Appoints Jeryl L. Hilleman to Board of Directors
Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of DirectorsBRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a...
Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and President
SAN MATEO, Calif., June 10, 2024 /PRNewswire/ -- Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare...
Bye, Bye Brain Fog: Zurge’s Proprietary Coffee Blend Sharpens Memory and Increases Mental Clarity
Formulated with breakthrough ingredient CognatiQ, this all-natural coffee is like no other Irving, TX – Zurvita is changing the morning...
NextSense Honored as World Economic Forum Technology Pioneer
MOUNTAIN VIEW, Calif., June 6, 2024 /PRNewswire/ -- NextSense is proud to announce that it has been recognized as a...
Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer
Josep Catllà EVP, Chief Corporate Affairs Officer PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global...
QuantalX Partners with the University of Illinois Chicago, Towards Successful US Commercialization
NEW YORK, June 5, 2024 /PRNewswire/ -- QuantalX Neuroscience Ltd, a pioneering medical technology company, is delighted to announce its...
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE...
Ocular Therapeutix® to Host Investor Day on June 13, 2024
Company to highlight corporate strategy, clinical data, and development plans for AXPAXLI™ in wet AMD and NPDR Event to feature prominent...